WHO - partnership on HIV, hepatitis, STIs and tuberculosis

This cooperation, initiated in June 2022 with the WHO’s Department of HIV, Hepatitis and STIs (WHO/HHS), then extended to tuberculosis in November 2023 with the Department of the Global Tuberculosis Programme (WHO/GTP), aims to facilitate dialogue between the research conducted in the LMICs and national and global public health policies on a number of pre-identified priority themes.

This cooperation is based around 3 specific objectives:

1. Linking science and epidemiology, to improve the impact of research in LMICs;
2. Generating scientific evidence to support WHO norms and standards development for the achievement of three global HIV, Hepatitis, and STIs strategies 2022-2030 as well as the End TB Strategy; and
3. Identifying and addressing important issues in the response to the HIV, Hepatitis and STIs, and Tuberculosis public health threats through priority research programs.”